You just read:

Swissmedic approves Eisai's Inovelon® (rufinamide) oral suspension formulation for seizures associated with Lennox-Gastaut Syndrome in Switzerland

News provided by

Eisai Europe Limited

11 Jul, 2012, 00:01 BST